Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-08 Option Award |
2022-02-10 5:05 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Interim CEO, CFO |
546,500 | $0 | 546,500 (Direct) |
View |
2021-12-08 Tax Withholding |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
6,294 | $1.42 | 80,310 (Direct) |
View |
2021-12-08 Option Award |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
17,534 | $0 | 80,310 (Direct) |
View |
2021-04-15 Option Award |
2021-04-19 4:53 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
239,000 | $0 | 239,000 (Direct) |
View |
2021-03-22 Option Award |
2021-03-22 9:25 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
15,060 | $0 | 34,004 (Direct) |
View |
2020-06-11 Tax Withholding |
2020-06-15 7:40 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer |
5,266 | $3.25 | 34,004 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:40 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer |
15,060 | $0 | 34,004 (Direct) |
View |